Company intelligence
European Hematology Association (EHA)
"Towards a cure for all blood disorders"β
About European Hematology Association (EHA)
Borderless Hematology means creating an environment where knowledge and expertise have unlimited potential. It's where seasoned experience converges with youthful vigor, facilitating mutual inspiration in a seamless exchange of knowledge and collective learning. Through Borderless Hematology, we empower each member and foster a sense of shared ownership. This shapes not only the field of hematology, but also the lives of patients who depend on us. The future of hematology is within our reach. π’ππΏ π πΆπππΆπΌπ»: "Towards prevention, cure, and quality of life for all patients with blood disorders." π’ππΏ ππΆπππΌπΏπ - Conceptualized in 1987 - Launched in 1990 - Formally established in 1992 Over the years, initiatives led by our association and members have positioned us at the forefront of hematology in Europe. Progress in education, training, research support, and patient care have helped to further advance this specialty, so vital to our health. We're a global network, and we actively collaborate with national and international medical associations and societies, and with European authorities to further hematology interests. ππ²π ππ°ππΆππΆππΆπ²π - Knowledge: Advancing harmonized hematology education across Europe through the European Hematology Curriculum and the EHA Campus - Connection: Organizing the annual EHA Congress, attended by professionals from all over the world - Clinical excellence: Publishing HemaSphere, our open access journal and EHA's Clinical Practice Guidelines - Advocacy: Strengthening hematology's voice in Europe by furthering its interests at the highest level - Research: Support researchers with generous funding programs and bespoke trainings
Verified activity
Signals from European Hematology Association (EHA)
8 published signals
People
European Hematology Association (EHA) closed applications for its research training programs in one week, with CBTH and CRTH applications open on September 15, 2026.
Reported by European Hematology Association (EHA)
Presence & Recognition
European Hematology Association (EHA) hosted the LearningMondays challenge to submit answers anonymously to unlock detailed explanations
Reported by European Hematology Association (EHA)
People
European Hematology Association (EHA) CRTH 2026 cohort completed the program and improved ideas on good trial design, accurate budgeting, project pitching to pharma, and patient communication.
Reported by European Hematology Association (EHA)
Presence & Recognition
European Hematology Association (EHA) kicked off the second workshop of CRTH 2026 by patient advocate Jan Geissler.
Reported by European Hematology Association (EHA)
Presence & Recognition
European Hematology Association (EHA) announced that Prof RaΓΊl CΓ³rdoba MascuΓ±ano won the EHA Education and Mentoring award for 2026.
Reported by European Hematology Association (EHA)
Capital & Finance
European Hematology Association (EHA) extended the deadline for applications for the EHA Kick-Off Grant to September 10, 2026.
Reported by European Hematology Association (EHA)
Research & Knowledge
European Hematology Association (EHA) published a new clinical case study titled Sickle Cell Disease Treatment - Case 1 examining the clinical assessment, investigation, and multidisciplinary management of a pregnant patient with SCD.
Reported by European Hematology Association (EHA)
Presence & Recognition
European Hematology Association (EHA) monitors EU funding calls and shares them on its website
Reported by European Hematology Association (EHA)